Statin Use and the Progression of Coronary Artery Calcification in CKD: Findings From the KNOW-CKD Study

Jihyun Yang1, Kyu-Beck Lee1, Hyang Kim1

  • 1Division of Nephrology, Department of Internal Medicine, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.

PubMed

Insights

Statin use is linked to faster coronary artery calcification (CAC) progression in Korean adults with predialysis chronic kidney disease (CKD). This finding suggests statins may paradoxically accelerate CAC in this vulnerable patient group.

Area of Science:

  • Nephrology
  • Cardiology
  • Pharmacology

Background:

  • Statins are widely used to reduce cardiovascular disease (CVD) risk.
  • Previous research indicates statin use is associated with coronary artery calcification (CAC) progression in patients with preserved renal function or on dialysis.
  • The relationship between statin use and CAC progression in predialysis chronic kidney disease (CKD) remains largely unknown.

Purpose of the Study:

  • To investigate the association between statin use and the progression of coronary artery calcification (CAC) in Korean adults with predialysis chronic kidney disease (CKD).
  • To characterize the relationship between statin use and CAC progression within this specific patient cohort.

Main Methods:

  • Analysis of 1177 participants from the Korean Cohort Study for Outcome in Patients with Chronic Kidney Disease (KNOW-CKD).
  • Coronary artery calcium score (CACS) assessed via cardiac computed tomography at baseline and after 4 years.
  • CAC progression defined using the Sevrukov method; statin users defined as those using statins for ≥50% of the follow-up period.

Main Results:

  • After 4 years, 52.0% of participants showed CAC progression.
  • CAC progression was significantly more frequent in statin users (58.3%) compared to non-users (41.7%) (P < 0.001).
  • Multivariate-adjusted odds ratio for CAC progression was 1.78 (1.26-2.50) in statin users versus non-users.

Conclusions:

  • Statin use is significantly and independently associated with accelerated CAC progression in Korean patients with predialysis CKD.
  • Further research is necessary to understand the prognostic implications of statin-associated CAC progression in this population.
Abstract

Related Concept Videos

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT01:25

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT

Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...
3
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage kidney disease (ESKD). At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate...
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
Acute Coronary Syndrome III: Diagnostic studies01:30

Acute Coronary Syndrome III: Diagnostic studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
3
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...